Jiangsu Provincial People's Hospital, a subsidiary of Nanjing Medical University, is a company headquartered in Guangzhou, China. The firm operates hospitals.

Beijing Pediatrician Tongyuan Technology Development Co., Ltd., established on 2013-10-09, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;computer technology training;Import and export,Technology Import and Export,Agent import and export;business management;investment management;asset Management;Tax Consulting;design,make,acting,Place an ad;Conference Services;Undertake exhibition and display activities;packaging service;translation service;Sales of medical devicesΙ,IIkind,non-metallic ore,metal ore,metallic material,building materials,Chemical Products(Does not contain a class of precursor chemicals and dangerous goods),Equipment,Wujinjiaodian,Instrumentation,car(Passenger cars with less than nine seats are not included),computer,Software and Auxiliary Equipment,communication equipment,daily necessities,Clothing and shoes,knitted goods,Toy,sporting goods,hygiene products,cosmetic;Repair air conditioning and refrigeration equipment;type,copy;Optometry;Photographic Printing Services;Preventive Health Services(Does not include medical activities);hospital management;Health Advisory(Except for medical treatment activities subject to approval);health management(Except for medical treatment activities subject to approval);Sell ​​Books Online,electronic publication,Audio-visual products(The publication business license is valid until2022year04moon30day);Insurance agency;sell food;Sales of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III Medical Devices,Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Guangzhou Jiajian Medical Testing Co., Ltd., established on 2015-08-12, Business scope includes medical research and experimental development;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;internet sales(Except for products that require a license for sale);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Consulting and planning service;Biomass Energy Technology Services;Experimental analysis instrument sales;Remote Health Management Services;trade broker;Health Consulting Services(Does not include medical services);Educational Consulting Services(Education and training activities that do not include licensing approval);Information Consulting Service(Not including licensing information consulting services);Business agency service;copyright agent;medical service;Inspection and testing service;Import and export;Technology Import and Export;Internet Information Service for Medical Devices;Class III medical device business

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help their clients realize their research goals in the rapidly evolving world of genomics. The company has become a world-leader in NGS services, with 1,800 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 49 NGS-related patents, as well as the publishing of over 1850 customer research papers, often in well-respected publications such as Nature and Science. Company founder, Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 12 patents and authoring over 90 peer-reviewed publications that have been cited >15,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused Novogene’s services on performing sequencing AND providing informatics to fully empower and enable their customers to move forward rapidly and effectively in their scientific endeavors.

Public Health Rehabilitation (Shanghai) Biotechnology Co., Ltd., established on 2020-05-06, Business scope includes licensed projects:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Medical Research and Experimental Development;Intellectual Property Services;Technology intermediary service;internet data service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Domestic trade agent,housing lease,Non-residential real estate leases,Machinery and Equipment Leasing,Office equipment rental service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Ling'an Biotechnology Co., Ltd., established on 2015-07-29, Business scope includes biotechnology,medical technology,Technology development in the field of health technology,technical consulting,Technical Services,technology transfer,Computer hardware and software and auxiliary equipment,medical instruments,Edible produce,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,Investment Advisory,Business Consulting,Health Management Consulting. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Qidong Lingxing Medical Laboratory Co., Ltd., established on 2017-03-02, Business scope includes medical laboratory services(Clinical Cytomolecular Genetics Major,clinical microbiology major),Pathology Services,Biological Technology,Technology research and development in the field of medical technology,technical consulting,Technology transfer service,Computers and Auxiliary Equipment,Class I medical device,vegetable,fruit,General chemical product sales,Nutrition and Health Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Data processing and storage support services;Big data service;software development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanxi Pharmaceutical Group Bio-Gene Technology Co., Ltd., established on 2017-10-25, Business scope includes technology development in the field of biotechnology,Technology Transfer and Technical Services;Drug Wholesale and Drug Retail;Medical device management:Wholesale of medical equipment,retail,lease;food business:Pre-packaged food,bulk food,Sales of health food;Gene drug development;sales of cosmetics;Chinese herbal medicine planting(Only used when setting up a branch);advertising business;Conference organization.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

GenomiCare Biotechnology (Shanghai) Co. Ltd. is a Chinese company located in Shanghai. The firm develops a precision cancer medicine service platform. It was founded in 2015 by Qiang Xu, he has been the CEO since that date.\nThe company says this about itself: GenomiCare Biotechnology, based in both China and the United States, leverages its unique real-world data and expansive clinical network across China, to bring real-world oncology solutions to global pharma and biotech companies seeking real-world market understanding to accelerate regulatory approval and optimize market access of innovation, break-through, cancer therapeutics to cancer patients with critical and continuing unmet medical needs.

Shanghai Jiexi Biotechnology Co., Ltd. (hereinafter referred to as Jiexi Biotechnology) was established on April 3, 2018. It is a technology enterprise specializing in biotechnology, computer technology, molecular diagnosis and other businesses. Anwo Gene, its platform, focuses on maternal and infant gene detection, deepens the layout of big data, relies on the GenoPBTM&Anwo Tiangang TM big data platform, and is committed to providing tens of millions of new women, new mothers, and new families in China with a scientific healthy lifestyle and a healthy management concept, and building a "cause+" healthy lifestyle platform. main products New Mom Baby allergy, baby nutrition, child height, learning motivation, baby intestinal flora, obesity risk, Chinese Scholar's Six Arts potential, children's mental health, pregnant mother's health, postpartum recovery, etc. New women Skin care for constipation, slimming body management, overall health during pregnancy and childbirth, etc New family Listen to scientific sports, sleep soundly, run a marathon, etc